by Simran Chahal | Mar 13, 2018 | News
Honored to be recognized by “Ready to Rocket” as one of the 10 featured Life Sciences companies to experience accelerated growth. We’re excited for the future! About Ready to Rocket: Ready to Rocket is a unique business recognition list that profiles...
by Simran Chahal | Feb 3, 2018 | News
As a founding member, we are thrilled that the BC-led #DigitalSupercluster has been chosen. Truly an exciting day for technology innovation in Canada! Read full story
by Simran Chahal | Jan 3, 2018 | News
Augurex CEO Norma Biln was awarded Canada’s Most Powerful Women: Top 100 Award for her extraordinary leadership and continued drive to inspire others. The Top 100 Award Winner community now includes 1,005 remarkable women who together celebrate accomplishments,...
by Simran Chahal | Nov 1, 2017 | News
At the world’s premier arthritis conference, the American College of Rheumatology Annual Meeting (ACR), taking place in San Diego on November 3rd-8th, leading investigators from the United States, Canada and Egypt will present new data on the 14-3-3η blood test....
by Simran Chahal | Oct 17, 2017 | News
NEWS RELEASE | OCTOBER 17, 2017 Vancouver, BC — Augurex Life Sciences Corp is proud to announce that 14-3-3η, a novel rheumatoid arthritis (RA) biomarker, is paving a future for better patient outcomes. Today the U.S Patent and Trademark Office (USPTO) has issued...
by Simran Chahal | Jun 15, 2017 | News
Vancouver, BC – June 13, 2017. At the annual European congress of rheumatology meeting, The European League Against Rheumatism (EULAR), taking place in Madrid, Spain on June 14-17, investigators present the continued understanding of 14-3-3η’s role in rheumatoid...
